| 05/19/2026 8:04 AM | Kadia Siddhartha (1573666) Reporting Mesa Laboratories (724004) Issuer | Form 4/A | |
| 04/24/2026 9:41 AM | Kadia Siddhartha (1573666) Reporting Mesa Laboratories (724004) Issuer | Form 3 Initial statement of beneficial ownership of securities | |
| 04/24/2026 9:49 AM | Kadia Siddhartha (1573666) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/15/2026 11:11 AM | Long Path Smaller Companies Fund, LP (1748049) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G/A | |
| 03/27/2026 9:49 AM | Mesa Laboratories (724004) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 03/23/2026 3:25 PM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/13/2026 3:40 PM | Long Path Smaller Companies Fund, LP (1748049) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G | |
| 03/10/2026 4:43 PM | Ladiwala Shiraz Shabanali (1715573) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 7:00 AM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/03/2026 7:01 AM | Mesa Laboratories (724004) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 12/05/2025 10:10 AM | Mesa Laboratories (724004) Issuer Sullivan John James (1305784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MLAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.
|
| 11/06/2025 3:51 PM | Mesa Laboratories (724004) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 10/31/2025 10:02 AM | Mesa Laboratories (724004) Subject VANGUARD GROUP INC (102909) Filed by | Form SCHEDULE 13G/A | |
| 10/28/2025 2:08 PM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 5:46 PM | BlackRock, Inc. (2012383) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G/A | |
| 08/25/2025 2:13 PM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/18/2025 1:37 PM | Ladiwala Shiraz Shabanali (1715573) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 1:20 PM | Mesa Laboratories (724004) Issuer Sullivan John James (1305784) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 12:34 PM | Alltoft Jennifer Sadie (1769053) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 12:45 PM | Capone Mark Christopher (1352413) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 12:54 PM | Mesa Laboratories (724004) Issuer Tripeny R Tony (1339381) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 1:02 PM | Hall Shannon (1621222) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 1:03 PM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/05/2025 7:00 AM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/05/2025 7:01 AM | Mesa Laboratories (724004) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/18/2025 11:06 AM | BlackRock, Inc. (2012383) Filed by Mesa Laboratories (724004) Subject | Form SCHEDULE 13G/A | |
| 07/11/2025 7:00 AM | Mesa Laboratories (724004) Filer | Form DEF 14A | |
| 06/25/2025 8:14 AM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/25/2025 8:05 AM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/24/2025 9:12 AM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 4:39 PM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 4:31 PM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/20/2025 4:22 PM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 11:04 AM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 11:12 AM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 11:18 AM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 10:27 AM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 10:13 AM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/18/2025 9:59 AM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/16/2025 2:40 PM | Mesa Laboratories (724004) Subject Sakys John (1197710) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/16/2025 2:47 PM | Mesa Laboratories (724004) Subject Owens Gary M (1700671) Reporting | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history.
But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing |
| 06/16/2025 2:49 PM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/11/2025 9:23 AM | Archbold Brian David (1776947) Reporting Mesa Laboratories (724004) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2025 9:30 AM | Mesa Laboratories (724004) Issuer Sakys John (1197710) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/11/2025 9:16 AM | Mesa Laboratories (724004) Issuer Owens Gary M (1700671) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/06/2025 2:00 PM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2025 7:00 AM | Mesa Laboratories (724004) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/28/2025 7:01 AM | Mesa Laboratories (724004) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |